Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTGS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TXNDC12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGSNAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LYST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00290 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CYP19A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNMB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD226 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on